Goldman Sachs’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.62M Buy
+181,300
New +$3.63M ﹤0.01% 4190

Other funds holding ADRX

Goldman Sachs's ADRX Position: Q3 2026 in Review

Goldman Sachs opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 181,300 shares worth $3.62M. The stake represents ﹤0.01% of the portfolio and ranks #4190 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Goldman Sachs held 181,300 shares of ADARx Pharmaceuticals worth $3.62M as of Q3 2026.
  • ADARx Pharmaceuticals was a new Goldman Sachs position in Q3 2026.
  • ADARx Pharmaceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #4190 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.